Purpose: This study was designed to evaluate and compare the efficacy of early treatment of CRVO with either hemodilution by erythrocytopheresis or intravitreal (IVT) ranibizumab, or both.
Material And Methods: A multicentric prospective randomized study including patients with CRVO for less than 1 month was designed. Patients were randomized into 3 treatment groups: hemodilution (HD group), 3 monthly intravitreal injections of ranibizumab followed by PRN treatment (IVT group), or combined treatment (IVT+HD group).
Purpose: To evaluate the benefit of anti-VEGF in the treatment of anterior segment neovascularization (ASNV), a severe complication of ischemic central retinal vein occlusion (CRVO).
Patients And Methods: This is a retrospective case series of consecutive patients with ASNV secondary to CRVO treated with anti-VEGF. Ophthalmic parameters were recorded for each visit: measurement of best visual acuity (VA), intraocular pressure (IOP), iris examination, gonioscopy and fundus examination, and as necessary, fluorescein angiography and optical coherence tomography.
Purpose: Extensive macular atrophy with pseudodrusen-like appearance (EMAP) is a recently described entity. We describe the first observations of choroidal neovascularization (CNV) associated with EMAP in 3 patients.
Methods: Nineteen consecutive patients with EMAP were retrospectively investigated for the presence of CNV and treatment outcomes.
Purpose: To report, in vivo, on the quasi-histologic characteristics of a sarcoid choroidal granuloma as visualized by Enhanced Depth Imaging Spectral Domain Optical Coherence Tomography (EDI SD-OCT).
Methods: A 49 year-old woman showing a choroidal granuloma secondary to sarcoidosis was imaged by EDI OCT.
Result: On EDI SD-OCT examination, sarcoid choroidal granuloma appears as a localized hyporeflectivechoroidalthickening.